SCHEMBL15917034

SCHEMBL15917034

CC(C)(C)C(=O)CS(=O)(=O)c1ccccc1Br

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.62
PLCG1 P19174 1/20 0.56
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
POLB P06746 2/20 0.39
RECQL P46063 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
EDNRA P25101 2/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
EDNRB P24530 1/20 0.36
RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11226379 0.79 PLCG1 (0.60) PLCG1CA1CA2CA4CA6
SCHEMBL6129827 0.77 HSD11B1 (1.00) HSD11B1POLBRECQLKMT2A
SCHEMBL28911450 0.76 PLCG1 (0.56) HSD11B1PLCG1CA1CA2CA4
SCHEMBL15916539 0.76 PLCG1 (0.51) PLCG1CA1CA2CA4CA6
SCHEMBL1814352 0.75 PLCG1 (0.72) PLCG1CA1CA2CA4CA6
SCHEMBL31378576 0.75 PLCG1 (0.72) PLCG1CA1CA2CA4CA6
SCHEMBL4250234 0.73 PLCG1 (1.00) PLCG1CA1CA2CA4CA6
SCHEMBL4432532 0.71 PLCG1 (0.64) PLCG1CA1CA2CA4CA6
SCHEMBL15846216 0.71 PLCG1 (0.64) PLCG1CA1CA2CA4CA6
SCHEMBL5083652 0.70 PLCG1 (0.69) PLCG1CA1CA2CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 US disclosed
EP-2951170-A2 FLAP MODULATORS Janssen Pharmaceutica, N.V. (BE) 2015-12-09 EP disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
WO-2014121055-A2 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-07 WO disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R HSD11B1 173/4885PLCG1 779/4885CA1 3447/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R HSD11B1 203/4885PLCG1 795/4885CA1 3615/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R HSD11B1 203/4885PLCG1 795/4885CA1 3615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.